Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Turner, K. Basu, L. Bignell, J. Ayres, R. Tavendale, B. Lipworth, A. Mehta, S. Mukhopadhyay, C. Palmer (Aberdeen, Brighton, Birmingham, Dundee, United Kingdom). Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?. Eur Respir J 2013; 42: Suppl. 57, 3497

Member's Comments

No comment yet.

Related content which might interest you: Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Side effects of the leukotriene receptor antagonists in asthmatic children Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Pharmacological treatment of asthma today Source: Eur Respir J 2001; 18: 34S-40S Year: 2001 Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Abediterol, a novel long-acting inhaled beta2-agonist, has a fast association rate and long residence time at human beta2 receptors Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Asthma in children Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=278 Year: 2003 Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review Source: Annual Congress 2011 - Asthma management and response Year: 2011 ?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies Source: Eur Respir J 2012; 39: 558-566 Year: 2012 Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Long acting ß2-agonist or leukotriene receptor antagonist in asthmatics at step 3 of BTS guidelines? Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 First line anti-inflammatory treatment for asthma: inhaled steroid or leukotriene antagonist? Source: Eur Respir J 2002; 20: Suppl. 38, 93s Year: 2002 Efficacy and safety of abediterol, a long-acting beta2-adrenergic agonist (LABA); three phase II trials in asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Salmeterol response is not affected by beta2-adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005